This inventor holds 3 USPTO granted patents. Top assignee: Teikoku Hormone Mfg. Co., Ltd.. Active years: 1981-1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1981-1990
Title: The Innovations of Nobuaki Yamakoshi
Introduction
Nobuaki Yamakoshi is a prominent inventor based in Kawasaki, Japan. He has made significant contributions to the field of pharmaceutical compounds, particularly in the development of compositions that target androgen-dependent diseases. With a total of 3 patents to his name, Yamakoshi continues to push the boundaries of innovation in his field.
Latest Patents
Yamakoshi's latest patents include groundbreaking work on 2-oxa- or -aza-pregnan compounds. One of his notable inventions is a compound represented by a specific formula, wherein A represents a hydrogen atom or a lower alkanoyl group, Z represents an oxygen atom or a particular group, and X represents a halogen atom. This compound is particularly useful for controlling androgen-dependent diseases, especially in preventing abortion or for contraception. Another patent focuses on a similar compound that aids in controlling androgen-dependent diseases, particularly for preventing prostatic hypertrophy.
Career Highlights
Yamakoshi is currently associated with Teikoku Hormone Mfg. Co., Ltd., where he applies his expertise in pharmaceutical innovations. His work has been instrumental in advancing the understanding and treatment of various medical conditions related to hormonal imbalances.
Collaborations
Throughout his career, Yamakoshi has collaborated with notable colleagues, including Kenyu Shibata and Naoyuki Koizumi. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to the development of effective pharmaceutical solutions.
Conclusion
Nobuaki Yamakoshi's contributions to the field of pharmaceutical compounds are noteworthy. His innovative patents and collaborations reflect his commitment to advancing medical science. As he continues to work at Teikoku Hormone Mfg. Co., Ltd., his impact on the industry is expected to grow.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile